Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30003803
Basic Information
VIS ID
TVIS30003803
Fusion event
HIV-E2F3 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr6
Cytoband
p22.3
Reference genome
GRCh37/hg19
Start
20428976/20428745 (Hg38)
End
20428976/20428745 (Hg38)
Orient
-
Location type
Intronic
Target gene
E2F3
miRNAs that regulate target gene
hsa-mir-195-5p
;
hsa-mir-34c-5p
;
hsa-mir-34a-5p
;
hsa-mir-210-3p
;
hsa-mir-128-3p
;
hsa-mir-125b-5p
;
hsa-mir-17-5p
;
hsa-mir-20a-5p
;
hsa-mir-106b-5p
;
hsa-mir-203a-3p
;
hsa-mir-200b-3p
;
hsa-mir-141-3p
;
hsa-mir-221-3p
;
hsa-mir-101-3p
;
hsa-mir-32-5p
;
hsa-mir-24-3p
;
hsa-mir-149-5p
;
hsa-mir-30c-5p
;
hsa-mir-16-5p
;
hsa-let-7b-5p
;
hsa-mir-449a
;
hsa-mir-217
;
hsa-mir-15a-5p
;
hsa-mir-15b-5p
;
hsa-mir-497-5p
;
hsa-mir-4496
;
hsa-mir-6868-5p
;
hsa-mir-3123
;
hsa-mir-3128
;
hsa-mir-3925-5p
;
hsa-mir-92a-3p
;
hsa-mir-92b-3p
;
hsa-mir-302a-5p
;
hsa-mir-449b-5p
;
hsa-mir-4302
;
hsa-mir-4773
;
hsa-mir-6499-3p
;
hsa-mir-6867-5p
;
hsa-mir-183-3p
;
hsa-mir-103b
;
hsa-mir-4645-3p
;
hsa-mir-4680-3p
;
hsa-mir-5579-3p
;
hsa-mir-93-5p
;
hsa-mir-20b-5p
;
hsa-mir-519d-3p
;
hsa-mir-3620-3p
;
hsa-mir-4715-3p
;
hsa-mir-4732-3p
;
hsa-mir-7849-3p
;
hsa-mir-885-3p
;
hsa-mir-5197-5p
;
hsa-mir-224-3p
;
hsa-mir-522-3p
;
hsa-mir-4694-3p
;
hsa-mir-100-3p
;
hsa-mir-2110
;
hsa-mir-3153
;
hsa-mir-4453
;
hsa-mir-4538
;
hsa-mir-4668-5p
;
hsa-mir-5093
;
hsa-mir-6124
;
hsa-mir-6733-5p
;
hsa-mir-6739-5p
;
hsa-mir-4272
;
hsa-mir-8065
;
hsa-mir-573
;
hsa-mir-660-5p
;
hsa-mir-3616-5p
;
hsa-mir-4795-5p
;
hsa-mir-577
;
hsa-mir-1245b-3p
;
hsa-mir-5583-3p
;
hsa-mir-1233-5p
;
hsa-mir-188-3p
;
hsa-mir-6871-5p
;
hsa-mir-145-5p
;
hsa-mir-200c-3p
;
hsa-mir-4314
;
hsa-mir-4642
;
hsa-mir-6780b-5p
;
hsa-mir-4725-3p
;
hsa-mir-4271
;
hsa-mir-6734-5p
;
hsa-mir-4316
;
hsa-mir-1294
;
hsa-mir-765
;
hsa-mir-6738-5p
;
hsa-mir-5194
;
hsa-mir-1914-3p
;
hsa-mir-423-5p
;
hsa-mir-3184-5p
;
hsa-mir-1825
;
hsa-mir-4695-5p
;
hsa-mir-199b-5p
;
hsa-mir-199a-5p
;
hsa-mir-548t-5p
;
hsa-mir-548az-5p
;
hsa-mir-548n
;
hsa-mir-376b-3p
;
hsa-mir-376a-3p
;
hsa-mir-425-5p
;
hsa-mir-590-5p
;
hsa-mir-21-5p
;
hsa-mir-32-3p
;
hsa-mir-548g-3p
;
hsa-mir-548av-3p
;
hsa-mir-607
;
hsa-mir-3671
;
hsa-mir-3156-5p
;
hsa-mir-3064-3p
;
hsa-mir-3156-3p
;
hsa-mir-1260b
;
hsa-mir-1260a
;
hsa-mir-548au-3p
;
hsa-mir-5588-5p
;
hsa-mir-4720-5p
;
hsa-mir-4799-3p
;
hsa-mir-4778-5p
;
hsa-mir-26a-1-3p
;
hsa-mir-200c-5p
;
hsa-mir-377-3p
;
hsa-mir-128-1-5p
;
hsa-mir-125a-5p
;
hsa-mir-503-5p
;
hsa-mir-874-3p
;
hsa-mir-1206
;
hsa-mir-139-3p
;
hsa-mir-140-5p
;
hsa-mir-203a-5p
;
hsa-mir-4524a-3p
;
hsa-mir-4524b-3p
;
hsa-mir-490-5p
Nearest miRNA
hsa-mir-3691/Upstream/1856865; hsa-mir-10398/Downstream/6718881;
Nearest TSS
ENST00000381078/Upstream/25066;
ENST00000613575/Downstream/105712;
Nearest CpG islands
None/Target,
chr6-CpG: 120/Upstream/25193
,
chr6-CpG: 131/Downstream/1158445
Nearest cancer related gene
E2F3
(OG, No orient, 0)
Upstream sequence
GATACGTGCTAAGCAAAGATTAGAGTTGGTGCTGAAAACAGGTCTCTTGCCTAAATCTTGGATTAGTACACAACTTCCACATATAAAGAGTTAGGGGCAT
Downstream sequence
CTTTAGGTAGATAAATCTATTTTAATTGTTCCGTAAATATATTTAGAAGAATTTTGGTCAACATGGATTTGGTGCAAATTTCGTTGCAGCTTTTTTTCCC
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Active CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate